Frontiers in anti-infective drug discovery.: Volume 9 /
"This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combina...
Gespeichert in:
Weitere Verfasser: | , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Sharjah, UAE :
Bentham Science Publishers,
[2021]
|
Schlagworte: | |
Online-Zugang: | Volltext |
Zusammenfassung: | "This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.The ninth volume of this series features 5 reviews that cover some aspects of clinical and pre-clinical antimicrobial drug development, with 2 chapters focusing on drugs to treat leishmaniasis and dengue fever, respectively.- Use of preclinical and early clinical data for accelerating antimicrobial drug development- Post-translational modifications: host defence mechanism, pathogenic weapon, and emerged target of anti-infective drugs- Scope and limitations on the potent antimicrobial activities of hydrazone derivatives- Current scenario of anti-leishmanial drugs and treatment- Dengue hemorrhagic fever: the potential repurposing drugs."-- |
Beschreibung: | 1 online resource |
Bibliographie: | Includes bibliographical references. |
ISBN: | 9781681088297 1681088290 |
Internformat
MARC
LEADER | 00000cam a2200000Mi 4500 | ||
---|---|---|---|
001 | ZDB-4-EBA-on1255342665 | ||
003 | OCoLC | ||
005 | 20241004212047.0 | ||
006 | m d | ||
007 | cr ||||||||||| | ||
008 | 210606s2021 ts ob 000 0 eng d | ||
040 | |a YDX |b eng |c YDX |d UKAHL |d N$T |d OCLCF |d OCLCQ |d OCLCO |d OCLCL |d TMA |d OCLCQ | ||
019 | |a 1262314004 | ||
020 | |a 9781681088297 |q (electronic bk.) | ||
020 | |a 1681088290 |q (electronic bk.) | ||
020 | |z 9781681088303 | ||
035 | |a (OCoLC)1255342665 |z (OCoLC)1262314004 | ||
050 | 4 | |a RM265 | |
082 | 4 | |a 615.7/92 |2 23/eng/20220517 | |
049 | |a MAIN | ||
245 | 0 | 0 | |a Frontiers in anti-infective drug discovery. |n Volume 9 / |c edited by Atta-ur-Rahman, FRS King's College, University of Cambridge, Cambridge, UK & M. Iqbal Chaudhary, H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan. |
264 | 1 | |a Sharjah, UAE : |b Bentham Science Publishers, |c [2021] | |
300 | |a 1 online resource | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
520 | |a "This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.The ninth volume of this series features 5 reviews that cover some aspects of clinical and pre-clinical antimicrobial drug development, with 2 chapters focusing on drugs to treat leishmaniasis and dengue fever, respectively.- Use of preclinical and early clinical data for accelerating antimicrobial drug development- Post-translational modifications: host defence mechanism, pathogenic weapon, and emerged target of anti-infective drugs- Scope and limitations on the potent antimicrobial activities of hydrazone derivatives- Current scenario of anti-leishmanial drugs and treatment- Dengue hemorrhagic fever: the potential repurposing drugs."-- |c Provided by publisher | ||
504 | |a Includes bibliographical references. | ||
650 | 0 | |a Anti-infective agents. |0 http://id.loc.gov/authorities/subjects/sh85005613 | |
650 | 0 | |a Communicable diseases. |0 http://id.loc.gov/authorities/subjects/sh85029015 | |
650 | 2 | |a Anti-Infective Agents |0 https://id.nlm.nih.gov/mesh/D000890 | |
650 | 2 | |a Communicable Diseases |0 https://id.nlm.nih.gov/mesh/D003141 | |
650 | 6 | |a Antiinfectieux. | |
650 | 6 | |a Maladies infectieuses. | |
650 | 7 | |a Anti-infective agents |2 fast | |
650 | 7 | |a Communicable diseases |2 fast | |
700 | 1 | |a Rahman, Atta-ur-, |d 1942- |e editor. |1 https://id.oclc.org/worldcat/entity/E39PBJx8yHRKtPYdRvxrTpJYyd |0 http://id.loc.gov/authorities/names/n81151677 | |
700 | 1 | |a Chaudhary, M. Iqbal, |e editor. | |
758 | |i has work: |a FRONTIERS IN ANTIFECTIVE DRUG DISCOVERY (Text) |1 https://id.oclc.org/worldcat/entity/E39PCXtRPXFM7Ph48GvQjxKHVK |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2938751 |3 Volltext |
938 | |a YBP Library Services |b YANK |n 302230627 | ||
938 | |a Askews and Holts Library Services |b ASKH |n AH38976182 | ||
938 | |a EBSCOhost |b EBSC |n 2938751 | ||
994 | |a 92 |b GEBAY | ||
912 | |a ZDB-4-EBA | ||
049 | |a DE-863 |
Datensatz im Suchindex
DE-BY-FWS_katkey | ZDB-4-EBA-on1255342665 |
---|---|
_version_ | 1816882545147510785 |
adam_text | |
any_adam_object | |
author2 | Rahman, Atta-ur-, 1942- Chaudhary, M. Iqbal |
author2_role | edt edt |
author2_variant | a u r aur m i c mi mic |
author_GND | http://id.loc.gov/authorities/names/n81151677 |
author_facet | Rahman, Atta-ur-, 1942- Chaudhary, M. Iqbal |
building | Verbundindex |
bvnumber | localFWS |
callnumber-first | R - Medicine |
callnumber-label | RM265 |
callnumber-raw | RM265 |
callnumber-search | RM265 |
callnumber-sort | RM 3265 |
callnumber-subject | RM - Therapeutics and Pharmacology |
collection | ZDB-4-EBA |
ctrlnum | (OCoLC)1255342665 |
dewey-full | 615.7/92 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615.7/92 |
dewey-search | 615.7/92 |
dewey-sort | 3615.7 292 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03699cam a2200493Mi 4500</leader><controlfield tag="001">ZDB-4-EBA-on1255342665</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">210606s2021 ts ob 000 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">YDX</subfield><subfield code="b">eng</subfield><subfield code="c">YDX</subfield><subfield code="d">UKAHL</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">TMA</subfield><subfield code="d">OCLCQ</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">1262314004</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781681088297</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1681088290</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781681088303</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1255342665</subfield><subfield code="z">(OCoLC)1262314004</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RM265</subfield></datafield><datafield tag="082" ind1=" " ind2="4"><subfield code="a">615.7/92</subfield><subfield code="2">23/eng/20220517</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Frontiers in anti-infective drug discovery.</subfield><subfield code="n">Volume 9 /</subfield><subfield code="c">edited by Atta-ur-Rahman, FRS King's College, University of Cambridge, Cambridge, UK & M. Iqbal Chaudhary, H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Sharjah, UAE :</subfield><subfield code="b">Bentham Science Publishers,</subfield><subfield code="c">[2021]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.The ninth volume of this series features 5 reviews that cover some aspects of clinical and pre-clinical antimicrobial drug development, with 2 chapters focusing on drugs to treat leishmaniasis and dengue fever, respectively.- Use of preclinical and early clinical data for accelerating antimicrobial drug development- Post-translational modifications: host defence mechanism, pathogenic weapon, and emerged target of anti-infective drugs- Scope and limitations on the potent antimicrobial activities of hydrazone derivatives- Current scenario of anti-leishmanial drugs and treatment- Dengue hemorrhagic fever: the potential repurposing drugs."--</subfield><subfield code="c">Provided by publisher</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Anti-infective agents.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85005613</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Communicable diseases.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85029015</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Anti-Infective Agents</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D000890</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Communicable Diseases</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D003141</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Antiinfectieux.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Maladies infectieuses.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anti-infective agents</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Communicable diseases</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rahman, Atta-ur-,</subfield><subfield code="d">1942-</subfield><subfield code="e">editor.</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJx8yHRKtPYdRvxrTpJYyd</subfield><subfield code="0">http://id.loc.gov/authorities/names/n81151677</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chaudhary, M. Iqbal,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">FRONTIERS IN ANTIFECTIVE DRUG DISCOVERY (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCXtRPXFM7Ph48GvQjxKHVK</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2938751</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">302230627</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH38976182</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">2938751</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
id | ZDB-4-EBA-on1255342665 |
illustrated | Not Illustrated |
indexdate | 2024-11-27T13:30:19Z |
institution | BVB |
isbn | 9781681088297 1681088290 |
language | English |
oclc_num | 1255342665 |
open_access_boolean | |
owner | MAIN DE-863 DE-BY-FWS |
owner_facet | MAIN DE-863 DE-BY-FWS |
physical | 1 online resource |
psigel | ZDB-4-EBA |
publishDate | 2021 |
publishDateSearch | 2021 |
publishDateSort | 2021 |
publisher | Bentham Science Publishers, |
record_format | marc |
spelling | Frontiers in anti-infective drug discovery. Volume 9 / edited by Atta-ur-Rahman, FRS King's College, University of Cambridge, Cambridge, UK & M. Iqbal Chaudhary, H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan. Sharjah, UAE : Bentham Science Publishers, [2021] 1 online resource text txt rdacontent computer c rdamedia online resource cr rdacarrier "This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.The ninth volume of this series features 5 reviews that cover some aspects of clinical and pre-clinical antimicrobial drug development, with 2 chapters focusing on drugs to treat leishmaniasis and dengue fever, respectively.- Use of preclinical and early clinical data for accelerating antimicrobial drug development- Post-translational modifications: host defence mechanism, pathogenic weapon, and emerged target of anti-infective drugs- Scope and limitations on the potent antimicrobial activities of hydrazone derivatives- Current scenario of anti-leishmanial drugs and treatment- Dengue hemorrhagic fever: the potential repurposing drugs."-- Provided by publisher Includes bibliographical references. Anti-infective agents. http://id.loc.gov/authorities/subjects/sh85005613 Communicable diseases. http://id.loc.gov/authorities/subjects/sh85029015 Anti-Infective Agents https://id.nlm.nih.gov/mesh/D000890 Communicable Diseases https://id.nlm.nih.gov/mesh/D003141 Antiinfectieux. Maladies infectieuses. Anti-infective agents fast Communicable diseases fast Rahman, Atta-ur-, 1942- editor. https://id.oclc.org/worldcat/entity/E39PBJx8yHRKtPYdRvxrTpJYyd http://id.loc.gov/authorities/names/n81151677 Chaudhary, M. Iqbal, editor. has work: FRONTIERS IN ANTIFECTIVE DRUG DISCOVERY (Text) https://id.oclc.org/worldcat/entity/E39PCXtRPXFM7Ph48GvQjxKHVK https://id.oclc.org/worldcat/ontology/hasWork FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2938751 Volltext |
spellingShingle | Frontiers in anti-infective drug discovery. Anti-infective agents. http://id.loc.gov/authorities/subjects/sh85005613 Communicable diseases. http://id.loc.gov/authorities/subjects/sh85029015 Anti-Infective Agents https://id.nlm.nih.gov/mesh/D000890 Communicable Diseases https://id.nlm.nih.gov/mesh/D003141 Antiinfectieux. Maladies infectieuses. Anti-infective agents fast Communicable diseases fast |
subject_GND | http://id.loc.gov/authorities/subjects/sh85005613 http://id.loc.gov/authorities/subjects/sh85029015 https://id.nlm.nih.gov/mesh/D000890 https://id.nlm.nih.gov/mesh/D003141 |
title | Frontiers in anti-infective drug discovery. |
title_auth | Frontiers in anti-infective drug discovery. |
title_exact_search | Frontiers in anti-infective drug discovery. |
title_full | Frontiers in anti-infective drug discovery. Volume 9 / edited by Atta-ur-Rahman, FRS King's College, University of Cambridge, Cambridge, UK & M. Iqbal Chaudhary, H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan. |
title_fullStr | Frontiers in anti-infective drug discovery. Volume 9 / edited by Atta-ur-Rahman, FRS King's College, University of Cambridge, Cambridge, UK & M. Iqbal Chaudhary, H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan. |
title_full_unstemmed | Frontiers in anti-infective drug discovery. Volume 9 / edited by Atta-ur-Rahman, FRS King's College, University of Cambridge, Cambridge, UK & M. Iqbal Chaudhary, H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan. |
title_short | Frontiers in anti-infective drug discovery. |
title_sort | frontiers in anti infective drug discovery |
topic | Anti-infective agents. http://id.loc.gov/authorities/subjects/sh85005613 Communicable diseases. http://id.loc.gov/authorities/subjects/sh85029015 Anti-Infective Agents https://id.nlm.nih.gov/mesh/D000890 Communicable Diseases https://id.nlm.nih.gov/mesh/D003141 Antiinfectieux. Maladies infectieuses. Anti-infective agents fast Communicable diseases fast |
topic_facet | Anti-infective agents. Communicable diseases. Anti-Infective Agents Communicable Diseases Antiinfectieux. Maladies infectieuses. Anti-infective agents Communicable diseases |
url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2938751 |
work_keys_str_mv | AT rahmanattaur frontiersinantiinfectivedrugdiscoveryvolume9 AT chaudharymiqbal frontiersinantiinfectivedrugdiscoveryvolume9 |